As of July 2026, 50 paid clinical trials are recruiting for Cardiology in Los Angeles, California. Cardiology trials investigate SGLT-2 inhibitors, myosin modulators, lipid-lowering therapies, anti-inflammatory agents, and device-based interventions across heart failure, hypertension, AFib, and coronary artery disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Los Angeles has approximately 2,089 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Researchers run research studies in Los Angeles, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cedars-Sinai Medical Center | Breast Cancer, Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8 | 238 |
| Children's Hospital Los Angeles | Neuroblastoma, Acute Myeloid Leukemia, Anesthesia | 137 |
| University of California, Los Angeles | Alzheimer Disease, Depression, Focal Epilepsy | 113 |
| University of Southern California | Acute Pancreatitis, Amyotrophic Lateral Sclerosis, Breast Cancer | 102 |
| USC / Norris Comprehensive Cancer Center | Malignant Solid Neoplasm, Breast Carcinoma, Hematopoietic and Lymphatic System Neoplasm | 80 |
| Cedars Sinai Medical Center | Anxiety, Aortic Dissection, Crohn's Disease | 74 |
| UCLA / Jonsson Comprehensive Cancer Center | Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8, Prostate Adenocarcinoma | 70 |
| University of California Los Angeles | Parkinson Disease, Bladder Cancer, Breast Cancer | 70 |
| Los Angeles General Medical Center | Metastatic Malignant Solid Neoplasm, Stage IVB Prostate Cancer AJCC v8, Unresectable Malignant Solid Neoplasm | 65 |
| USC Norris Comprehensive Cancer Center | Colorectal Cancer, Endometrial Cancer, NSCLC | 56 |
| UCLA | Bladder Cancer, Colorectal Cancer, Type2diabetes | 54 |
| Kaiser Permanente Los Angeles Medical Center | Stage IV Lung Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Intracerebral Hemorrhage | 48 |
| Children's Hospital of Los Angeles | Acute Lymphoblastic Leukemia, Cystic Fibrosis, Von Willebrand Disease (VWD) | 39 |
| Valkyrie Clinical Trials | Multiple Myeloma, Solid Tumors, Breast Cancer | 35 |
| Ronald Reagan UCLA Medical Center | Ischemic Stroke, Stroke, Esophageal Adenocarcinoma | 28 |
| USC/Norris Comprehensive Cancer Center | Breast Neoplasms, Bladder Cancer, Breast Cancer | 24 |
| UCLA Medical Center | Colorectal Cancer, CRC, Cancer | 21 |
| Kaiser Permanente West Los Angeles | Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | 19 |
| Keck Medicine of USC Koreatown | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 18 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Non-alcoholic Fatty Liver Disease, Breast Neoplasms | 14 |
| David Geffen School of Medicine at UCLA | Developmental and Epileptic Encephalopathy, Candidemia, Candidiasis, Invasive | 14 |
| Keck Hospital of USC | Advanced Hepatocellular Carcinoma, Advanced or Metastatic Solid Tumors, Airway Disease | 14 |
| University of California, Los Angeles (UCLA) | Metastatic Cancer, Adamantinomatous Craniopharyngioma, Adenosine Deaminase Severe Combined Immune Deficiency | 14 |
| Mattel Children's Hospital UCLA | Malignant Solid Neoplasm, Ganglioneuroblastoma, Nodular, Hematopoietic and Lymphatic System Neoplasm | 13 |
| UCLA Health | Adult Growth Hormone Deficiency, Cancer, Chronic Disease | 13 |
Recruiting trials in Los Angeles grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Hipa.ai aggregates every recruiting study in Los Angeles from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 2,089 recruiting clinical trials in Los Angeles, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Los Angeles compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Los Angeles include Breast Cancer (44), Colorectal Cancer (30), Prostate Cancer (28), Cancer (22), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Los Angeles on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Los Angeles include Cedars-Sinai Medical Center, Children's Hospital Los Angeles, University of California, Los Angeles, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Los Angeles are Cancer & tumors (673), Neurology & pain (123), Cardiovascular (98). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.